Next Up

Biologics 2024

13 - 15 March 2024 |

London, UK

13 - 15 March 2024

London, UK

Europe’s Premier Meeting for Biologics R&D

Sep 2024
September 2024

mRNA Vaccines & Oligonucleotide Therapies 2024Ā Ā 

Sep 2024
September 2024

Biologics US 2024

Highlights

Introducing the Development and Clinical Landscape of Bi and Multispecific Antibodies
Industry Spotlight
While bispecific antibodies target two specific entities, multispecific antibodies can target more than two. The use of these engineered antibodies offers the potential for enhanced therapeutic strategies by simultaneously addressing multiple aspects of a disease.
Edited by Tom Cohen |
16 November 2023
Proteins & Antibodies
Industry Spotlight
Edited by Ben Norris |
13 Nov 2023
Proteins & Antibodies
Post-Event Report
03 Nov 2023
Biologics Series

In-Depth

Insight Article
How are oligo therapeutics revolutionising genetic disease treatments through precise targeting and transformative therapies? In this article, we explore how they provide precise gene expression interference for untreatable conditions by directly targeting disease-associated proteins and genetic mutations.
01 August 2023
Insight Article
As cancer treatments continue to develop, bispecific cell engagers are revolutionising this therapeutic landscape.
10 July 2023

Industry Spotlight

Industry Spotlight
While bispecific antibodies target two specific entities, multispecific antibodies can target more than two. The use of these engineered antibodies offers the potential for enhanced therapeutic strategies by simultaneously addressing multiple aspects of a disease.
16 November 2023
Industry Spotlight
Advancements in cytokine understanding and synthetic immunology enable precise immune modulation, particularly in cancer treatment. However, challenges like short half-lives and side effects impact their wider clinical application.
13 November 2023
Industry Spotlight
Discussing using a computational drug discovery platform for the development of multispecific antibody therapeutics.
27 October 2023
Industry Spotlight
How do we prepare for the next pandemic?
26 October 2023